Latest News
Press background on Alkem Laboratories Ltd.
Company profile
Established in 1973 and headquartered in Mumbai, Alkem (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and International markets. With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales (Source: IQVIA data March 2020). The Company also has presence in more than 40 international markets, with the United States being its key focus market.
 Recent press releases
Alkem Laboratories Limited Partners with Tata Memorial Hospital to Establish State of Art Cancer Care Facility at Muzaffarpur, Bihar

Alkem Laboratories Limited (“Alkem”) has agreed to partner with Tata Memorial Centre (“TMC”) to establish an advanced Radiotherapy Facility as a part of the Homi Bhabha Cancer Hospital and Research Center (“HBCHRC”), Muzaffarpur. As part of Alkem’s ... (more)
Alkem Makes Epilepsy Treatment More Accessible & Affordable with the Launch of BRIVASURE (Brivaracetam)

Epilepsy is a common neurological disorder. Of the 70 million persons with epilepsy (PWE) worldwide, nearly 12 million PWE are expected to reside in India; which contributes to nearly one-sixth of the global burden.1
Brivaracetam has shown promise in patients with epilepsy whose... (more)